Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average.
Left:
||||
Revenue minus cost of goods sold
Latest
$149.41M
↑ 45% above average
Average (9y)
$102.71M
Historical baseline
Range
High:$438.16M
Low:$-182.64M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $149.41M | +52.1% |
| 2023 | $98.25M | -30.3% |
| 2022 | $140.96M | -47.6% |
| 2021 | $268.96M | -38.6% |
| 2020 | $438.16M | +29.3% |
| 2019 | $338.99M | +20290.2% |
| 2018 | $-1.68M | +98.9% |
| 2017 | $-158.97M | -147.1% |
| 2016 | $-64.33M | +64.8% |
| 2015 | $-182.64M | - |